<DOC>
	<DOCNO>NCT02684747</DOCNO>
	<brief_summary>A total 40 subject recruit participation study . 20 subject ( 10 male 10 female ) randomize active group ( receive re-infusion autologous blood ) 20 subject ( 10 male 10 female ) randomize placebo group ( receive NS infusion ) .</brief_summary>
	<brief_title>Detecting Autologous Transfusion Measuring Alterations Dynamics Red Blood Cell Maturation Recycling</brief_title>
	<detailed_description>Autologous blood transfusion major problem wide range competitive sport . Methods increase sensitivity , specificity , feasibility need identify athletes cheat manner compromise health integrity sport general . Complete blood count ( CBC ) offer routine high-resolution assessment current hematologic status individual , provide estimate number blood characteristic , total hemoglobin concentration blood ( HGB ) volume fraction cell blood ( HCT ) . These CBC component homeostatically control carefully regulate dynamic process red blood cell ( RBC ) production release bone marrow , RBC maturation peripheral circulation course ~100-day RBC lifespan , clearance recycle senescent cell . Any significant perturbation circulate population RBCs , like autologous transfusion , immediately trigger compensatory modulation one dynamic process . The investigator believe quantification underlie dynamic process enable u detect autologous transfusion . These dynamic RBC process currently measure directly , novel mathematical modeling enables inference routine complete blood reticulocyte count . The investigator propose test ability model RBC dynamic identify instance autologous blood transfusion .</detailed_description>
	<criteria>1 . Male female 1835 year old 2 . Classified low risk major sign symptom suggestive cardiovascular , pulmonary , metabolic disease accord American College Sports Medicine 's ( ACSM ) risk stratification category 3 . The subject welltrained endurance athlete . This group could consist cyclist ( road mountain ) , triathletes , runner , longdistance swimmer , etc . 1 . Age le 18 great 35 day enrollment 2 . Any contraindication blood donation define American Association Blood Banks http : //www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/QuestionsaboutBlood/UCM272981.pdf 3 . Any chronic illness ( e.g.diabetes , heart disease , hypotension , anemia , hemoglobinopathy , marrow disease , leukemia/lymphoma , pregnancy , amenorrhea/female athlete triad ) 4 . Any abnormal CBC index iron study ; blood dyscrasia 5 . Abnormal blood urine test dope agent ( e.g . phthalates ) 6 . Positive uhCG woman attempt get pregnant study period 7 . Unwilling unable provide blood sample receive blood transfusion 8 . Not participant endurance sport activity 9 . Are currently medication might affect hematologic parameter include , restrict , hematopoietic medication 10 . Subjects baseline hemoglobin 16.7 g/dL , baseline hematocrit 35 % 55 % . 11 . Any subject plan participate organize athletic event ( USA Cycling sanction event ) within 30 day follow reinfusion phase study allow participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Sports Medicine</keyword>
	<keyword>Athletes</keyword>
	<keyword>Anti-doping</keyword>
</DOC>